Spondyloarthropathies News

COVID-19 is more severe, with more complications and higher mortality, than influenza among patients with autoimmune disease, according to data published in Rheumatology.

Researchers found significantly lower treatment rates for women with ankylosing spondyloarthritis in multiple studies analyzing clinical trials in axial spondylarthritis, resulting in poor outcomes and response to therapies once started.

Healio Rheumatology compiled a list of the news in ankylosing spondylitis, including expert insight on pain management, drug updates and tips on diagnosis.

Patient voices are growing louder in rheumatology. The calls for shared decision-making and a dual target strategy of assessing disease remission are increasing with a body of evidence showing that when patient needs are met, outcomes improve.

This episode details how psoriatic arthritis and the spondyloarthropathies came to be recognized as a distinct clinical entity after decades of nerdy arguing.

Twitter use revealed “early signals” of drug rationing and other critical behavior changes in patients with rheumatic diseases as they navigated the early months of the COVID-19 pandemic, according to data published in Rheumatology.

During the early months of the COVID-19 pandemic, increased all-cause mortality in patients with rheumatoid arthritis and other inflammatory joint diseases largely mirrored that of the general population, according to data.

Arthritis and hypertension are the two most prevalent chronic conditions among U.S. veterans aged 25 years and older, according to data published by CDC researchers in National Health Statistics Report.

Moderate and high disease activity, as well as the use of immunosuppressants, were associated with a higher risk for COVID-related death in patients with rheumatic diseases, according to data in the Annals of the Rheumatic Diseases.

Patients’ response to anti-CTLA-4 or anti-PD-1 checkpoint therapy for advanced melanoma, and their incidence of immune-related adverse events of grade 3 or higher, were similar regardless of preexisting autoimmune disease, according to data.